Search research articles
Contact Us
Filters
Showing results (311-320 of 362) with videos related to
Page
of 37
Sort By:
American Heart Journal
|
May 13, 2015
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
Rhonda Bentley-Lewis, David Aguilar, Matthew C Riddle, et al.
Circulation. Heart Failure
|
November 16, 2024
Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical Trials
Pablo M Marti-Castellote, Christopher Reeder, Brian Claggett, et al.
Circulation
|
October 15, 2020
Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction
Daniel Modin, Brian Claggett, Caroline Sindet-Pedersen, et al.
Journal of the American College of Cardiology
|
February 28, 2024
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI
Douglas L Mann, Johny Nicolas, Brian Claggett, et al.
European Journal of Heart Failure
|
December 18, 2024
Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial data
Offer Amir, Gabby Elbaz-Greener, Shemy Carasso, et al.
JACC. Heart Failure
|
September 2, 2025
Angiotensin-Neprilysin Inhibition and Left Ventricular Assist Device Therapy -Primary results of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 LVAD recipients (ENVAD-HF)
Maja Cikes, Jasper J Brugts, Brian Claggett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 23, 2018
Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Finnian R Mc Causland, Brian Claggett, Emmanuel A Burdmann, et al.
JAMA Cardiology
|
January 24, 2024
Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction: A Post Hoc Analysis of the DELIVER Trial
Orly Vardeny, Akshay S Desai, Pardeep S Jhund, et al.
Journal of Cardiac Failure
|
January 12, 2024
Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study
G Michael Felker, Scott D Solomon, Marco Metra, et al.
European Journal of Heart Failure
|
December 15, 2024
Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HF
Xiaowen Wang, Orly Vardeny, Brian Claggett, et al.
Page
of 37
Search research articles
Search
Showing results (311-320 of 362) with videos related to
Sort By:
Page
of 37
American Heart Journal
|
May 13, 2015
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
Rhonda Bentley-Lewis, David Aguilar, Matthew C Riddle, et al.
Circulation. Heart Failure
|
November 16, 2024
Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical Trials
Pablo M Marti-Castellote, Christopher Reeder, Brian Claggett, et al.
Circulation
|
October 15, 2020
Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction
Daniel Modin, Brian Claggett, Caroline Sindet-Pedersen, et al.
Journal of the American College of Cardiology
|
February 28, 2024
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI
Douglas L Mann, Johny Nicolas, Brian Claggett, et al.
European Journal of Heart Failure
|
December 18, 2024
Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial data
Offer Amir, Gabby Elbaz-Greener, Shemy Carasso, et al.
JACC. Heart Failure
|
September 2, 2025
Angiotensin-Neprilysin Inhibition and Left Ventricular Assist Device Therapy -Primary results of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 LVAD recipients (ENVAD-HF)
Maja Cikes, Jasper J Brugts, Brian Claggett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 23, 2018
Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Finnian R Mc Causland, Brian Claggett, Emmanuel A Burdmann, et al.
JAMA Cardiology
|
January 24, 2024
Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction: A Post Hoc Analysis of the DELIVER Trial
Orly Vardeny, Akshay S Desai, Pardeep S Jhund, et al.
Journal of Cardiac Failure
|
January 12, 2024
Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study
G Michael Felker, Scott D Solomon, Marco Metra, et al.
European Journal of Heart Failure
|
December 15, 2024
Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HF
Xiaowen Wang, Orly Vardeny, Brian Claggett, et al.
Page
of 37